Papers: 10.1186/s13287-017-0508-3

https://doi.org/10.1186/s13287-017-0508-3

Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance

Cited by: 9
Author(s): Kunal H. Bhatt, Rajeev Rudraraju, Jeremy F. Brooks, Ji‐Won Jung, Ryan Galea, James W. Wells, Raymond J. Steptoe
Published: over 9 years ago

Software Mentions 1